MedPath

iving kidney donation and the kinetics of proenkephalin.

Conditions
Kidney injury
Registration Number
NL-OMON26466
Lead Sponsor
Radboudumc
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Male or female > 18 years old
-Living kidney donor
-Baseline kidney function: eGFR > 60 mL/min
-Able and willing to provide informed consent

Exclusion Criteria

No exclusion criteria

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
•PENK plasma concentration prior to and following kidney donation compared to the kinetics of tubular injury markers<br>•Neutrophil gelatinase-associated lipocalin (NGAL) and TIMP-2*IGFBP7 (Nephrocheck) and functional markers (creatinine and cystatin C plasma concentrations)<br>
Secondary Outcome Measures
NameTimeMethod
•Association between PENK and estimated GFR (using serum creatinine and cystatin C) following kidney donation<br>•Association between PENK and endogenous creatinine clearance after donating kidney.<br>•Association between peak PENK and creatinine concentrations<br>
© Copyright 2025. All Rights Reserved by MedPath